
ADCT
Healthcare · Drug Manufacturers - Specialty & Generic · $188.5M market cap
$1.34-0.07 (-5.0%)Nov 13, 4:00 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +1.9% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 10, 2027 · upcoming | Before the open | -0.20 | — | — |
| Nov 9, 2026 | Before the open | -0.21 | -0.16 | +23.8% |
| Aug 13, 2026 | Before the open | -0.19 | -0.11 | +42.1% |
| May 4, 2026 | Before the open | -0.20 | -0.21 | -5.0% |
| Mar 12, 2026 | Time not confirmed | -0.30 | -0.04 | +86.6% |
| Nov 10, 2025 | Before the open | -0.36 | -0.30 | +16.7% |
| Aug 12, 2025 | Before the open | -0.48 | -0.50 | -4.2% |
| May 5, 2025 | Before the open | -0.41 | -0.36 | +13.1% |
| Mar 27, 2025 | Before the open | -0.41 | -0.29 | +29.3% |
| Nov 7, 2024 | Before the open | -0.39 | -0.42 | -7.7% |
| Aug 6, 2024 | Before the open | -0.46 | -0.38 | +17.4% |
| May 6, 2024 | Before the open | -0.56 | -0.56 | 0.0% |
| Mar 13, 2024 | Before the open | -0.50 | -1.03 |
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or…
| -106.0% |
| Nov 7, 2023 | Before the open | -0.63 | -0.58 | +7.9% |
| Aug 8, 2023 | Before the open | -0.57 | -0.58 | -1.8% |
| May 9, 2023 | Before the open | -0.67 | -0.74 | -10.4% |
| Feb 28, 2023 | Before the open | -0.05 | -0.10 | -100.0% |
| Nov 8, 2022 | Before the open | -0.10 | 0.13 | +230.0% |
| Aug 9, 2022 | Before the open | -0.76 | -0.73 | +3.9% |
| May 9, 2022 | Before the open | -0.67 | -0.22 | +67.2% |
| Mar 3, 2022 | Before the open | -0.86 | -0.45 | +47.7% |
| Nov 2, 2021 | Before the open | -0.73 | -0.59 | +19.2% |
| Aug 3, 2021 | Before the open | -0.86 | -0.95 | -10.5% |
| May 6, 2021 | Before the open | -0.90 | -0.67 | +25.6% |
| Mar 18, 2021 | Before the open | -0.38 | -1.05 | -176.3% |
| Nov 12, 2020 | Before the open | -0.82 | -0.58 | +29.3% |
| Aug 18, 2020 | Before the open | -0.65 | -0.51 | +21.5% |
| Jun 3, 2020 | Time not confirmed | -0.56 | -0.77 | -37.5% |
| Sep 23, 2019 | Time not confirmed | — | -0.84 | — |